Clinical Examination of a Patient with Diabetes

Last updated: March 10, 2026

Assessment of a patient with newly diagnosed diabetes

Look for evidence of:

  • Weight loss – seen in Type 1 DM
  • Obesity – seen in Type 2 DM
  • Dehydration – dry mucous membranes, reduced skin turgor
  • Mucosal candidiasis
  • Clinical features of:
    • Cushing’s syndrome
      • Centrally distributed fat
      • Skin changes: Thinning, bruising, striae
      • Buffalo hump
      • Moon facies
      • Raised blood pressure
      • Proximal myopathy – difficulty getting up from a seat
    • Acromegaly
      • Coarse features
      • Prognathism with spaced-out lower teeth
      • Enlarged hands and feet
      • Elevated blood pressure
  • Kussmaul breathing – ketoacidosis
  • syndromic features
  • Sweet acetone smell on breath – ketoacidosis
  • Skin
    • Cellulitis
    • Skin ulcers
    • Abscesses
    • Fungal infections
    • Acanthosis nigricans
    Examination of the feet will be handled in a different section.
  • Signs of dyslipidemia
    • Xanthelasmata
    • Xanthomatas
  • Measure blood pressure and pulse
  • Hands
    • Limited joint mobility (‘cheiroarthropathy’) causes painless stiffness. The inability to extend (to 180°) the metacarpophalangeal or interphalangeal joints of at least one finger bilaterally can be demonstrated in the ‘prayer sign’.
    • Muscle-wasting/sensory changes may be present in peripheral sensorimotor neuropathy, although this is more common in the lower limbs
  • Facial nerve palsy
    • Microcirculatory insufficiency due to peripheral vascular disease is seen in the causes of facial palsy, characterized by sudden hemifacial weakness.
  • Visual acuity and fundoscopy – screen for diabetic retinopathy
  • Hepatomegaly – fatty infiltration of the liver
  • Legs
  • Neck
    • Carotid pulse
    • Bruits
    • Thyroid enlargement

Routine Review of a known DM patient

  • Weight measurement
    • Loss of weight in type 1 DM indicates insulin deficiency
    • An increase in weight in type 2 DM indicates increased insulin resistance
  • Mucosal candidiasis
  • Examine hands as mentioned above
  • Measure BP and pulse
  • Test visual acuity and fundoscopy
  • Routine investigations
  • Examine injection sites for (Sites to look at: Anterior abdominal wall, upper thighs and buttocks, upper, outer arms)
    • Lipohypertrophy – causes unpredictable insulin release
    • Lipoatrophy
    • Infection
    Examination of a Diabetic Foot You’re worried about:
    • Neuropathy
    • Ischemia
    • Infection
    • A mix of all of these
    • Inspection
      • Hair loss and nail dystrophy – fungal infections, etc
      • Discoloration – gangrene
      • Pallor – ischemia
      • Excessive calluses
      • Clawing of toes – neuropathy
      • Skin breaks, ulcers – ischemic ulcers are found on the tips of toes
      • Loss of plantar arch – ask the patient to stand
      • Joint deformity – Charcot neuropathy
    • Palpation Vascular
      • Palpate peripheral pulses – dorsalis pedis and posterior tibial arteries
      • Skin temperature
        • Warm – neuropathy
        • Cold – ischemia
      • Capillary refill
      Peripheral Neuropathy
      • Use a 10g monofilament to apply a standard, reproducible stimulus at specific points
        • Used as a form of risk assessment
        • If it perceives less than 8 out of ten then there is an increased risk for ulceration
        • Note sensory deficiency in a stocking pattern
      • Test for vibration and proprioception
      • Test for ankle and plantar reflexes
    • Charcot arthropathy
      • Progressive condition characterised by joint dislocation, pathological fractures, and deformity
      • Occurs in DM most commonly, but can be seen in:
        • Chronic alcoholism
        • Leprosy
        • Syphllis
        • Spinal cord injury
        • Renal dialysis
      • Thought to occur due to unperceived trauma or injury to an insensate foot resulting from sensory neuropathy renders the patient unaware of the osseous destruction that occurs with ambulation.
      • This microtrauma leads to progressive destruction and damage to bone and joints.
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *